2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET4 response as an independent predictor of long-term outcomes in ECHELON2 (A+CHP vs. CHOP) in CD30+PTCL
    Meeting Abstract

    Iyer, S. P.; Mehta-Shah, N.; Advani, R. H.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domenech, E. D.; Pagani, C.; Kim, W. S.; Alpdogan, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (liso-cel) in patients (pts) with R/R MCL: Subgroup analyses in pts with high-risk disease features from the MCL cohort of the TRANSCEND NHL 001
    Meeting Abstract

    Palomba, M. L.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M. A.; Hirayama, A. V.; Abramson, J. S.; Arnason, J. E.; Ghosh, N.; Mehta, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma treated with venetoclax: A multicenter retrospective analysis
    Meeting Abstract

    Sawalha, Y.; Sarosiek, S. R.; Welkie, R. L.; Seif, S.; Thapa, S.; Zanwar, S.; Cahill, K.; Treitman, R.; Shah, H.; Arora, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 1 study of PIT565, a first-in-class, anti-CD3, anti-CD19, anti-CD2 trispecific antibody in patients with relapsed and/or refractory B-cell malignancies
    Meeting Abstract

    Mazza, I. A.; Barba, P.; Yuda, J.; Palomba, M. L.; Alderuccio, J. P.; De Vriendt, C.; Corradini, P.; Lim, F. L. W. I.; Zinzani, P. L.; Jain, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of therapy sequence on survival outcomes among patients with relapsed or refractory mature T and NK cell neoplasms: A global retrospective cohort study
    Meeting Abstract

    Sorial, M. N.; Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Eche-Ugwu, I. J.; Duan, R.; Lei, M. M.; Miranda, E.; Chiattone, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Strategies to develop anti-KIR mab lacutamab in patients with peripheral T-cell lymphoma: Preliminary monotherapy clinical data and pre-clinical combinability data
    Meeting Abstract

    Iyer, S. P.; Ayyappan, S. R.; Greenwell, I. B.; Kim, W. S.; Lee, S. T.; Kim, J. S.; Lee, W. S.; Jeon, Y.; Johnson, W.; Dave, U. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of sequential CD19-directed therapies in relapsed and refractory large B cell lymphoma
    Meeting Abstract

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M. H.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G.; Romancik, J. T.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An updated comparison of clinical outcomes from 4-year follow-up of ZUMA-5 (axicabtagene ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma
    Meeting Abstract

    Gribben, J. G.; Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Blood (2023)

    Fulltext@MSK | Save